Answers are grounded in this paper and cite their sources.
A biochemical screening program produces a great deal of laboratory data at small unit cost to the patient, but at considerable cost to the whole patient population. No evidence is available that its introduction is medically justified.
No takes yet. Share an insight, caveat, or question.
Robert C. Ahlvin (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: